NCT07039396View on ClinicalTrials.gov

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

January 1, 2026

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

NeoThelium FT (HCT/P 361)

NeoThelium FT (HCT/P 361) is a dehydrated wound covering derived from donated human placental tissue. NeoThelium FT is a dual-layer membrane with amnion and chorion combination layers.

Trial Locations (1)

71301

RECRUITING

MedCentris of Alexandria, Alexandria

All Listed Sponsors
collaborator

SygNola, LLC

INDUSTRY

lead

NuScience Medical Biologics, LLC

INDUSTRY

NCT07039396 - Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter